Thermo Fisher Scientific Inc (TMO)
580.05
-4.10
(-0.70%)
USD |
NYSE |
Mar 18, 16:00
579.95
-0.10
(-0.02%)
Pre-Market: 07:19
Thermo Fisher Scientific Total Assets (Quarterly): 98.73B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 98.73B |
September 30, 2023 | 97.06B |
June 30, 2023 | 94.10B |
March 31, 2023 | 94.66B |
December 31, 2022 | 97.15B |
September 30, 2022 | 90.54B |
June 30, 2022 | 90.58B |
March 31, 2022 | 92.75B |
December 31, 2021 | 95.12B |
September 30, 2021 | 73.60B |
June 30, 2021 | 67.70B |
March 31, 2021 | 65.93B |
December 31, 2020 | 69.05B |
September 30, 2020 | 64.06B |
June 30, 2020 | 61.59B |
March 31, 2020 | 58.69B |
December 31, 2019 | 58.38B |
September 30, 2019 | 56.73B |
June 30, 2019 | 57.97B |
March 31, 2019 | 55.60B |
December 31, 2018 | 56.23B |
September 30, 2018 | 55.08B |
June 30, 2018 | 55.40B |
March 31, 2018 | 56.58B |
December 31, 2017 | 56.67B |
Date | Value |
---|---|
September 30, 2017 | 55.99B |
June 30, 2017 | 46.51B |
March 31, 2017 | 46.21B |
December 31, 2016 | 45.91B |
September 30, 2016 | 48.01B |
June 30, 2016 | 42.25B |
March 31, 2016 | 42.95B |
December 31, 2015 | 40.83B |
September 30, 2015 | 41.15B |
June 30, 2015 | 41.77B |
March 31, 2015 | 41.86B |
December 31, 2014 | 42.85B |
September 30, 2014 | 42.69B |
June 30, 2014 | 44.31B |
March 31, 2014 | 46.13B |
December 31, 2013 | 31.86B |
September 30, 2013 | 28.27B |
June 30, 2013 | 27.63B |
March 31, 2013 | 27.41B |
December 31, 2012 | 27.44B |
September 30, 2012 | 27.58B |
June 30, 2012 | 26.36B |
March 31, 2012 | 26.82B |
December 31, 2011 | 26.83B |
September 30, 2011 | 26.99B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
55.60B
Minimum
Mar 2019
98.73B
Maximum
Dec 2023
77.00B
Average
71.33B
Median
Total Assets (Quarterly) Benchmarks
Fonar Corp | 202.26M |
XWELL Inc | 44.55M |
ProPhase Labs Inc | 91.71M |
Applied DNA Sciences Inc | 9.913M |
OncoCyte Corp | 81.59M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 51.88B |
Shareholders Equity (Quarterly) | 46.74B |
Debt to Equity Ratio | 0.7471 |
Current Ratio | 1.755 |
Net Debt Paydown Yield | -0.56% |